European Journal of Dermatology

, Volume 28, Issue 5, pp 628–636 | Cite as

Chlamydia muridarum plasmid induces mouse oviduct pathology by promoting chlamydial survival and ascending infection and triggering host inflammation

  • Shuping Hou
  • Lu Yue
  • Rong Xu
  • Congzhong Zhu
  • Shijun Shan
  • Huiping Wang
  • Quanzhong LiuEmail author
Investigative report



Infection with plasmid-free Chlamydia trachomatis and Chlamydia muridarum fails to induce severe pathology, however, the mechanisms underlying this phenotype are unclear.


To elucidate the mechanisms of chlamydial plasmid-mediated pathology in mouse oviducts.

Materials & methods

BALB/c mice were intravaginally infected with either plasmid-competent or plasmid-free C. muridarum strains. To compare the survival and ascending infection of these strains, vaginal swabs and genital tract tissues were collected and cultured with HeLa cells to monitor the recovery of live organisms. In addition, Chlamydia strains were intrabursally inoculated into the oviducts of mice to assess pathogenicity. Cytokine levels in the vaginal swabs collected from both the plasmid-competent and plasmidfree C. muridarum-infected mice were detected using Bio-Plex Pro Mouse Cytokine, Chemokine, and Growth Factor Assays.


The plasmid-competent C. muridarum strain induced hydrosalpinx formation in mouse oviducts following intravaginal inoculation, however, this was not the case for the plasmid-free C. muridarum strain. The lack of hydrosalpinges in response to the plasmid-free C. muridarum strain correlated with its significantly reduced ability to survive and disseminate to the upper genital tract. Furthermore, the plasmid-free C. muridarum failed to induce hydrosalpinx formation in mice, even when the strain was intrabursally injected into oviducts. A comparison of the cytokine levels in mouse vaginal secretions showed that the plasmid-free C. muridarum strain induced less IL-15, LIF, MIP-2, IL-1-, IL-1α, TNF-α, and RANTES.


C. muridarum plasmid contributes to oviduct pathology by promoting bacterial survival and ascending infection, and triggering host inflammatory responses.

Key words

chlamydial plasmid pathology ascending infection inflammation 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    O’Connell CM, Ingalls RR, Andrews CW Jr., Scurlock AM, Darville T. Plasmid–deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J Immunol 2007; 179: 4027–34.CrossRefGoogle Scholar
  2. 2.
    Budrys NM, Gong S, Rodgers AK, et al. Chlamydia trachomatis antigens recognized in women with tubal factor infertility, normal fertility, and acute infection. Obstet Gynecol 2012; 119: 1009–16.CrossRefGoogle Scholar
  3. 3.
    Cotter TW, Meng Q, Shen ZL, Zhang YX, Su H, Caldwell HD. Protective efficacy of major outer membrane protein–specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection. Infect Immun 1995; 63: 4704–14.Google Scholar
  4. 4.
    Pal S, Peterson EM, de la Maza LM. Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria. Infect Immun 2005; 73: 8153–60.CrossRefGoogle Scholar
  5. 5.
    De la Maza LM, Pal S, Khamesipour A, Peterson EM. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility. Infect Immun 1994; 62: 2094–7.Google Scholar
  6. 6.
    Stephens RS. The cellular paradigm of chlamydial pathogenesis. Trends Microbiol 2003; 11: 44–51.CrossRefGoogle Scholar
  7. 7.
    Cheng W, Shivshankar P, Li Z, Chen L, Yeh IT, Zhong G. Caspase–1 contributes to Chlamydia trachomatis–induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 2008; 76: 515–22.CrossRefGoogle Scholar
  8. 8.
    Muramatsu MK, Brothwell JA, Stein BD, Putman TE, Rockey DD, Nelson DE. Beyond tryptophan synthase: identification of genes that contribute to Chlamydia trachomatis survival during gamma interferoninduced persistence and reactivation. Infect Immun 2016; 84: 2791–801.CrossRefGoogle Scholar
  9. 9.
    Carlson JH, Whitmire WM, Crane DD, et al. The Chlamydia trachomatis plasmid is a transcriptional regulator of chromosomal genes and a virulence factor. Infect Immun 2008; 76: 2273–83.CrossRefGoogle Scholar
  10. 10.
    Lei L, Chen J, Hou S, et al. Reduced live organism recovery and lack of hydrosalpinx in mice infected with plasmid–free Chlamydia muridarum. Infect Immun 2014; 82: 983–92.CrossRefGoogle Scholar
  11. 11.
    Chen C, Chen D, Sharma J, et al. The hypothetical protein CT813 is localized in the Chlamydia trachomatis inclusion membrane and is immunogenic in women urogenitally infected with C. trachomatis. Infect Immun 2006; 74: 4826–40.CrossRefGoogle Scholar
  12. 12.
    Cheng W, Shivshankar P, Li Z, Chen L, Yeh IT, Zhong G. Caspase–1 contributes to Chlamydia trachomatis–induced upper urogenital tract inflammatory pathologies without affecting the course of infection. Infect Immun 2008; 76: 515–22.CrossRefGoogle Scholar
  13. 13.
    Chen L, Lei L, Chang X, et al. Mice deficient in MyD88 develop a Th2–dominant response and severe pathology in the upper genital tract following Chlamydia muridarum infection. J Immunol 2010; 184: 2602–10.CrossRefGoogle Scholar
  14. 14.
    Pal S, Peterson EM, de la Maza LM. Intranasal immunization induces long–term protection in mice against a Chlamydia trachomatis genital challenge. Infect Immun 1996; 64: 5341–8.Google Scholar
  15. 15.
    Chen J, Zhang H, Zhou Z, et al. Chlamydial induction of hydrosalpinx in 11 strains of mice reveals multiple host mechanisms for preventing upper genital tract pathology. PLoS One 2014; 9: e95076.CrossRefGoogle Scholar
  16. 16.
    Thomas NS, Lusher M, Storey CC, Clarke IN. Plasmid diversity in Chlamydia. Microbiology 1997; 143: 1847–54.CrossRefGoogle Scholar
  17. 17.
    Li Z, Chen D, Zhong Y, Wang S, Zhong G. The chlamydial plasmid–encoded protein pgp3 is secreted into the cytosol of Chlamydia–infected cells. Infect Immun 2008; 76: 3415–28.CrossRefGoogle Scholar
  18. 18.
    Kari L, Goheen MM, Randall LB, et al. Generation of targeted Chlamydia trachomatis null mutants. Proc Natl Acad Sci USA 2011; 108: 7189–93.CrossRefGoogle Scholar
  19. 19.
    Song L, Carlson JH, Whitmire WM, et al. Chlamydia trachomatis plasmid–encoded Pgp4 is a transcriptional regulator of virulenceassociated genes. Infect Immun 2013; 81: 636–44.CrossRefGoogle Scholar
  20. 20.
    Gong S, Yang Z, Lei L, Shen L, Zhong G. Characterization of Chlamydia trachomatis plasmid–encoded open reading frames. J Bacteriol 2013; 195: 3819–26.CrossRefGoogle Scholar
  21. 21.
    Liu Y, Chen C, Gong S, et al. Transformation of Chlamydia muridarum reveals a role for Pgp5 in suppression of plasmid–dependent gene expression. J Bacteriol 2014; 196: 989–98.CrossRefGoogle Scholar
  22. 22.
    Liu Y, Huang Y, Yang Z, et al. Plasmid–encoded Pgp3 is a major virulence factor for Chlamydia muridarum to induce hydrosalpinx in mice. Infect Immun 2014; 82: 5327–35.CrossRefGoogle Scholar
  23. 23.
    Ramsey KH, Schripsema JH, Smith BJ, et al. Plasmid CDS5 influences infectivity and virulence in a mouse model of Chlamydia trachomatis urogenital infection. Infect Immun 2014; 82: 3341–9.CrossRefGoogle Scholar
  24. 24.
    Hou S, Dong X, Yang Z, Li Z, Liu Q, Zhong G. Chlamydial plasmid–encoded virulence factor Pgp3 neutralizes the antichlamydial activity of human cathelicidin LL–37. Infect Immun 2015; 83: 4701–9.CrossRefGoogle Scholar
  25. 25.
    Dong X, Liu Y, Chang X, Lei L, Zhong G. Signaling via tumor necrosis factor receptor 1 but not Toll–like receptor 2 contributes significantly to hydrosalpinx development following Chlamydia muridarum infection. Infect Immun 2014; 82: 1833–9.CrossRefGoogle Scholar
  26. 26.
    Murthy AK, Li W, Chaganty BK, et al. Tumor necrosis factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary genital Chlamydia muridarum infection. Infect Immun 2011; 79: 2928–35.CrossRefGoogle Scholar
  27. 27.
    Nagarajan UM, Sikes JD, Yeruva L, Prantner D. Significant role of IL–1 signaling, but limited role of inflammasome activation, in oviduct pathology during Chlamydia muridarum genital infection. J Immunol 2012; 188: 2866–75.CrossRefGoogle Scholar
  28. 28.
    Andrew DW, Cochrane M, Schripsema JH, et al. The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL–17 knockout mice but protection is not increased further by immunization. PLoS One 2013; 8: e76664.CrossRefGoogle Scholar
  29. 29.
    Lee HY, Schripsema JH, Sigar IM, et al. A role for CXC chemokine receptor–2 in the pathogenesis of urogenital Chlamydia muridarum infection in mice. FEMS Immunol Med Microbiol 2010; 60: 49–56.CrossRefGoogle Scholar

Copyright information

© John Libbey Eurotext 2018

Authors and Affiliations

  • Shuping Hou
    • 1
  • Lu Yue
    • 1
  • Rong Xu
    • 1
  • Congzhong Zhu
    • 1
  • Shijun Shan
    • 1
  • Huiping Wang
    • 1
  • Quanzhong Liu
    • 1
  1. 1.Department of DermatovenereologyTianjin Medical University General HospitalTianjinChina

Personalised recommendations